Abstract
γ-Hydroxybutyric acid (GHB) is an endogenous short-chain fatty acid popular as a recreational drug due to sedative and euphoric effects, but also often implicated in drug-facilitated sexual assaults owing to disinhibition and amnesic properties. Whilst discrimination between endogenous and exogenous GHB as required in intoxication cases may be achieved by the determination of the carbon isotope content, such information has not yet been exploited to answer source inference questions of forensic investigation and intelligence interests. However, potential isotopic fractionation effects occurring through the whole metabolism of GHB may be a major concern in this regard. Thus, urine specimens from six healthy male volunteers who ingested prescription GHB sodium salt, marketed as Xyrem®, were analysed by means of gas chromatography/combustion/isotope ratio mass spectrometry to assess this particular topic. A very narrow range of δ13C values, spreading from −24.81‰ to −25.06‰, was observed, whilst mean δ13C value of Xyrem® corresponded to −24.99‰. Since urine samples and prescription drug could not be distinguished by means of statistical analysis, carbon isotopic effects and subsequent influence on δ13C values through GHB metabolism as a whole could be ruled out. Thus, a link between GHB as a raw matrix and found in a biological fluid may be established, bringing relevant information regarding source inference evaluation. Therefore, this study supports a diversified scope of exploitation for stable isotopes characterized in biological matrices from investigations on intoxication cases to drug intelligence programmes.
Similar content being viewed by others
References
Maitre M (1997) Prog Neurobiol 51:337–361
Carter LP, Pardi D, Gorsline J, Griffiths RR (2009) Drug Alcohol Depend 104:1–10
Roth RH, Giarman NJ (1970) Biochem Pharmacol 19:1087–1093
Palmer RB (2004) Toxicol Rev 23:21–31
Carter LP, Koek W, France CP (2009) Pharmacol Ther 121:100–114
Mamelak M (2009) Prog Neurobiol 89:193–219
Gallimberti L, Spella MR, Soncini CA, Gessa GL (2000) Alcohol 20:257–262
Pardi D, Black J (2006) CNS Drugs 20:993–1018
Van Cauter E, Plat L, Scharf MB, Leproult R, Cespedes S, L'Hermite-Baleriaux M, Copinschi G (1997) J Clin Invest 100:745–753
Takahara J, Yunoki S, Yakushiji W, Yamauchi J, Yamane Y (1977) J Clin Endocrinol Metab 44:1014–1017
Ramo DE, Grov C, Delucchi K, Kelly BC, Parsons JT (2010) Drug Alcohol Depend 107:119–127
Maxwell JC (2005) Subst Use Misuse 40:1203–1240
Stillwell ME (2002) J Forensic Sci 47:1133–1134
Liechti ME, Kupferschmidt H (2004) Swiss Med Wkly 134:534–537
Hillebrand J, Olszewski D, Sedefov R (2008) GHB and its precursor GBL: an emerging trend case study. European Monitoring Centre for Drugs and Drug Addiction (EMCDDA), Lisbon
Knudsen K, Jonsson U, Abrahamsson J (2010) Acta Anaesthesiol Scand 54:987–992
Knudsen K, Greter J, Verdicchio M, Cederquist T (2005) Lakartidningen 102:3294–3296, 3299
Miro O, Nogue S, Espinosa G, To-Figueras J, Sanchez M (2002) J Toxicol Clin Toxicol 40:129–135
Wood DM, Warren-Gash C, Ashraf T, Greene SL, Shather Z, Trivedy C, Clarke S, Ramsey J, Holt DW, Dargan PI (2008) QJM 101:23–29
Abanades S, Farre M, Segura M, Pichini S, Barral D, Pacifici R, Pellegrini M, Fonseca F, Langohr K, De La Torre R (2006) Ann NY Acad Sci 1074:559–576
Andresen H, Sprys N, Schmoldt A, Mueller A, Iwersen-Bergmann S (2010) Forensic Sci Int 200:93–99
Crookes CE, Faulds MC, Forrest AR, Galloway JH (2004) J Anal Toxicol 28:644–649
Elliott SP (2003) Forensic Sci Int 133:9–16
Yeatman DT, Reid K (2003) J Anal Toxicol 27:40–42
LeBeau MA, Montgomery MA, Morris-Kukoski C, Schaff JE, Deakin A, Levine B (2006) J Anal Toxicol 30:98–105
Saudan C, Augsburger M, Mangin P, Saugy M (2007) Rapid Commun Mass Spectrom 21:3956–3962
Saudan C, Augsburger M, Kintz P, Saugy M, Mangin P (2005) J Anal Toxicol 29:777–781
Marclay F, Pazos D, Delemont O, Esseiva P, Saudan C (2010) Forensic Sci Int 198:46–52
Muccio Z, Jackson GP (2011) J Forensic Sci 56(Suppl 1):S203–S209
Collins M, Salouros H, Cawley AT, Robertson J, Heagney AC, Arenas-Queralt A (2010) Rapid Commun Mass Spectrom 24:1653–1658
David GE, Coxon A, Frew RD, Hayman AR (2010) Forensic Sci Int 200:123–129
Collins M, Cawley AT, Heagney AC, Kissane L, Robertson J, Salouros H (2009) Rapid Commun Mass Spectrom 23:2003–2010
Sewenig S, Fichtner S, Holdermann T, Fritschi G, Neumann H (2007) Isot Environ Health Stud 43:275–280
Casale JF, Ehleringer JR, Morello DR, Lott MJ (2005) J Forensic Sci 50:1315–1321
Galimov EM, Sevastyanov VS, Kulbachevskaya EV, Golyavin AA (2005) Rapid Commun Mass Spectrom 19:1213–1216
Buchanan HA, Daeid NN, Meier-Augenstein W, Kemp HF, Kerr WJ, Middleditch M (2008) Anal Chem 80:3350–3356
Booth AL, Wooller MJ, Howe T, Haubenstock N (2010) Forensic Sci Int 202:45–53
Kerrigan S (2002) J Anal Toxicol 26:571–574
LeBeau MA, Montgomery MA, Morris-Kukoski C, Schaff JE, Deakin A (2007) Forensic Sci Int 169:152–156
Berankova K, Mutnanska K, Balikova M (2006) Forensic Sci Int 161:158–162
Craig H (1957) Geochim Cosmochim Acta 12:133–149
Hillebrandt S, Bock HH, Matern S, Lammert F (2001) Dtsch Med Wochenschr 126:17–19
LeBeau MA, Christenson RH, Levine B, Darwin WD, Huestis MA (2002) J Anal Toxicol 26:340–346
Elian AA (2002) Forensic Sci Int 128:120–122
Villain M, Criminele V, Ludes B, Kintz P (2003) J Chromatogr B 792:83–87
Schmitt J, Glaser B, Zech W (2003) Rapid Commun Mass Spectrom 17:970–977
Ferrara SD, Frison G, Tedeschi L, Lebeau M (2001) Gamma-hydroxybutyrate (GHB) and related products. In: LeBeau M, Mozayani A (eds) Drug-facilitated sexual assault. Academic, San Diego, pp 107–126
Felmlee MA, Roiko SA, Morse BL, Morris ME (2010) J Pharmacol Exp Ther 333:764–771
Hayes J (2001) RiMG 43:225–277
Ludke SM, Flenker U, Schanzer W, Schomburg D (2008) J Lipid Res 49:2620–2626
Acknowledgements
The original study on Xyrem® effects on sleep was supported by an unrestricted research grant from UCB Pharma (Belgium).
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Marclay, F., Saudan, C., Vienne, J. et al. Source inference of exogenous gamma-hydroxybutyric acid (GHB) administered to humans by means of carbon isotopic ratio analysis: novel perspectives regarding forensic investigation and intelligence issues. Anal Bioanal Chem 400, 1105–1112 (2011). https://doi.org/10.1007/s00216-011-4891-9
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00216-011-4891-9